Marimed INC Form 4 insider transactions

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports the vesting of Restricted Stock Units (RSUs) and subsequent transactions involving common stock.

Chief Financial Officer of Marimed Inc., Mario Pinho, reports the acquisition of 214,286 Restricted Stock Units (RSUs) that will vest quarterly starting March 31, 2025.

Marimed Inc.'s Chief Operating Officer, Timothy Shaw, reported the acquisition of 243,750 restricted stock units (RSUs) and a change in beneficial ownership of common stock.

Marimed Inc.'s CEO, Jon R. Levine, reported the acquisition of 281,250 Restricted Stock Units (RSUs) and a decrease in indirect holdings of common stock.

Jon R. Levine, President and CEO of Marimed Inc., reports the vesting of Restricted Stock Units (RSUs) and subsequent tax withholding, resulting in changes to his beneficial ownership of common stock.

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports the vesting of restricted stock units and subsequent tax withholding, impacting his beneficial ownership of common stock.

Jon Levine, President and CEO of Marimed Inc., reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of common stock.

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports acquisition and disposal of common stock and Restricted Stock Units (RSUs) on September 7, 2024.

Jon Levine, President and CEO of Marimed Inc., reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of the company's common stock.

Timothy Shaw, Chief Operating Officer of Marimed Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Director Kathleen Tucker reports acquisition and disposal of Marimed Inc. stock and Restricted Stock Units (RSUs).

Director Eva Selhub reports acquisition and disposal of Marimed Inc. stock and Restricted Stock Units (RSUs).

Director Edward J. Gildea reports acquisition and disposal of Marimed Inc. stock and Restricted Stock Units (RSUs).

Director David R. Allen reports acquisition and disposal of Marimed Inc. stock and Restricted Stock Units (RSUs).

Timothy Shaw, Chief Operating Officer of Marimed Inc., reports the acquisition and disposal of common stock and Restricted Stock Units (RSUs).

Marimed's CEO, Jon Levine, reports stock transactions including RSU conversions and sales to cover tax obligations.

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports acquisition of restricted stock units and details of existing common stock holdings.

Jon R. Levine, President and CEO of Marimed Inc., reports acquisition of restricted stock units (RSUs) and updates to his beneficial ownership of common stock.

Marimed's Chief Operating Officer, Timothy Shaw, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Marimed Inc. CEO Jon Levine reported the vesting of restricted stock units (RSUs) and the subsequent sale of shares to cover tax obligations.